Alamar: The Consumables Flywheel Is Just Getting Started (NASDAQ:ALMR)
· seekingalpha.com
Alamar Biosciences is rated a buy, targeting a recurring consumables-driven model with expansion into clinical diagnostics. Learn more about ALMR stock here.
Alamar Biosciences, Inc. ( ALMR ) isn’t just trying to sell proteomics instruments here. Rather, they want to build a complete installed base from their custo...